GSK2606414
GSK2606414 is an orally available, potent, and selective PERK inhibitor with IC50 of 0.4 nM, displaying at least 100-fold selectivity over the other EIF2AKs assayed. GSK2606414 impairs GANT-61 induced autophagy in NB cells with MYCN amplification. GSK2606414 exacerbates ER stress-induced apoptosis in HCT116 cells while reduces the apoptosis in SIL1 KD HeLa cells.
Trivial name | N/A |
Catalog Number | S7307 |
Molecular Formula | C24H20F3N5O |
CAS# | 1337531-36-8 |
Inchi | InChI=1S/C24H20F3N5O/c1-31-12-18(21-22(28)29-13-30-23(21)31)15-5-6-19-16(11-15)7-8-32(19)20(33)10-14-3-2-4-17(9-14)24(25,26)27/h2-6,9,11-13H,7-8,10H2,1H3,(H2,28,29,30) |
Inchi Key | SIXVRXARNAVBTC-UHFFFAOYSA-N |
SMILES | CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F |
Size | 5mg |
Supplier Page | http://www.selleckchem.com/products/gsk2606414.html |
Additional Information | https://file.selleck.cn/downloads/struct/GSK2606414-chemical-structure-s7307.gif |